Clinical trial
Combination Drug Therapy for Patients With Hepatitis C
NCT00001729 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00001729 |
|---|---|
| Title | Combination Drug Therapy for Patients With Hepatitis C |
| Official title | Combination of Alpha Interferon With Long Term Ribavirin Therapy for Patients With Chronic Hepatitis C |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C, Fibrosis, Hemolytic Anemia |
| Intervention type | Drug |
| Interventions | Ribavirin |
| Enrollment | 120 |
| Start date | Oct 1, 1997 |
| Completion | Sep 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: